Human Genome Sciences, Inc. (HGSI) Announces Delivery of Anthrax Treatment to U.S. Strategic National Stockpile
Today, Human Genome Sciences announced that it has begun delivering 20,000 doses of its human monoclonal antibody drug ABthrax(TM) (raxibacumab)…